New schizophrenia pill shows promise in early trial
NCT ID NCT00862992
First seen Jan 06, 2026 · Last updated May 20, 2026 · Updated 24 times
Summary
This study tested a new medication called MP-214 in 34 adults with schizophrenia. Participants took the pill once daily for 14 days at different doses to see if it was safe and how the body processed it. The goal was to gather early information on side effects and drug levels, not to prove a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hoyu Hospital
Kure, Hiroshima, Japan
Conditions
Explore the condition pages connected to this study.